Exelixis announces positive results for its drug Cabometyx in the treatment of neuroendocrine tumors
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Data shows that this drug significantly reduced the risk of disease progression or death by 74% in patients with non-functional neuroendocrine tumors. Meanwhile, in the group of patients with functional neuroendocrine tumors, the risk reduction also reached 60%.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
USD/JPY: Intervention risk near 160 – Societe Generale
FXStreet•2026/11/12 10:33
Prices Under Pressure, Costs Rising! BHP (BHP.US) Plans to Restructure Its Australian Iron Ore Business, Layoffs May Further Expand
As part of a larger cost-cutting initiative, BHP plans to restructure its Australian iron ore operations.
智通财经•2026/11/12 10:30
US Dollar: Fed repricing supports stronger levels – MUFG
FXStreet•2026/11/12 10:21
Crypto prices
More
Bitcoin
BTC
$73,391.48
-0.70%
Ethereum
ETH
$2,044.43
-0.65%
Tether USDt
USDT
$0.9988
-0.01%
BNB
BNB
$672.11
-1.28%
USDC
USDC
$0.9998
+0.01%
XRP
XRP
$1.05
-1.26%
Solana
SOL
$83.01
-0.90%
TRON
TRX
$0.3164
-0.29%
Hyperliquid
HYPE
$71.69
-1.32%
Zcash
ZEC
$987.01
-0.03%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now